Buscar resultados de ensayos clínicos
Acute Erythroid Leukemia - 171 Studies Found
| Estado | Estudiar |
| Terminated |
Nombre del estudio: Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Condición:
|
| Terminated |
Nombre del estudio: Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant Condición:
|
| Completed |
Nombre del estudio: Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia Condición:
|
| Active, not recruiting |
Nombre del estudio: Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia Condición:
|
| Completed |
Nombre del estudio: Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia Condición:
|
| Terminated |
Nombre del estudio: Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia Condición:
|
| Active, not recruiting |
Nombre del estudio: Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia Condición:
|
| Active, not recruiting |
Nombre del estudio: Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Condición:
|
| Active, not recruiting |
Nombre del estudio: Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders Condición:
|
| Completed |
Nombre del estudio: Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase Condición:
|